$3m deal launches major hunt for drug leads in Brazil.
作者信息
Bonalume Neto R, Dickson D
出版信息
Nature. 1999 Jul 22;400(6742):302. doi: 10.1038/22393.
DOI:10.1038/22393
PMID:10432100
Abstract
摘要
相似文献
1
$3m deal launches major hunt for drug leads in Brazil.
Nature. 1999 Jul 22;400(6742):302. doi: 10.1038/22393.
2
Natural resources: bioprospects less than golden.
Nature. 2004 Jun 10;429(6992):598-600. doi: 10.1038/429598a.
3
Bills target biosimilar drugs.
Nature. 2009 Mar 26;458(7237):394-5. doi: 10.1038/458394b.
4
Navigating biotechnology's new fiscal opportunities.
Nat Biotechnol. 1998 May;16 Suppl:51-3. doi: 10.1038/5423.
5
Sarbanes-Oxley rules to be relaxed?
Nat Biotechnol. 2006 Jul;24(7):731-2. doi: 10.1038/nbt0706-731.
6
Patent fight sparks biological warfare in the drug industry.
Fortune. 2000 Jul 24;142(3):40, 42.
7
Patenting bioactive molecules from biodiversity: the Brazilian experience.
Expert Opin Ther Pat. 2010 Feb;20(2):145-57. doi: 10.1517/13543770903555221.
8
Biotech battle royale. Two firms fight over billion-dollar drug.
US News World Rep. 2000 Mar 20;128(11):52.
9
Big companies helped by safe harbour ruling.
Nat Rev Drug Discov. 2005 Jul;4(7):525-6. doi: 10.1038/nrd1789.
10
US, Brazil tangle over IP rights to drugs.
Nat Biotechnol. 2001 Aug;19(8):698. doi: 10.1038/90718.
Zotero 插件